BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 18363154)

  • 1. Hydrops fetalis in a neonate with down syndrome, transient myeloproliferative disorder and hepatic fibrosis.
    Anuk D; Tarcan A; Alioglu B; Avci Z; Haberal N; Ozyurek E; Ozbek N
    Fetal Pediatr Pathol; 2007; 26(5-6):223-8. PubMed ID: 18363154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome.
    Zipursky A; Brown EJ; Christensen H; Doyle J
    Clin Lab Med; 1999 Mar; 19(1):157-67, vii. PubMed ID: 10403079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.
    Brink DS
    Adv Anat Pathol; 2006 Sep; 13(5):256-62. PubMed ID: 16998319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trisomy 21, fetal hydrops, and anemia: prenatal diagnosis of transient myeloproliferative disorder?
    Hendricks SK; Sorensen TK; Baker ER
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):703-5. PubMed ID: 8378020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of dysplastic platelets by peripheral blood megakaryoblasts in transient myeloproliferative disorder in Down syndrome.
    Chopra A; Kumar R; Kabra M; Anand M
    Platelets; 2008 Mar; 19(2):160-1. PubMed ID: 18297553
    [No Abstract]   [Full Text] [Related]  

  • 6. Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21.
    Smrcek JM; Baschat AA; Germer U; Gloeckner-Hofmann K; Gembruch U
    Ultrasound Obstet Gynecol; 2001 May; 17(5):403-9. PubMed ID: 11380964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrauterine diagnosis and management of transient myeloproliferative disorder.
    Strobelt N; Ghidini A; Locatelli A; Vergani P; Mariani S; Biondi A
    Am J Perinatol; 1995 Mar; 12(2):132-4. PubMed ID: 7779196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biventricular hypertrophic non-obstructive cardiomyopathy as a symptom of transient myeloproliferative disorder in a newborn with Down syndrome].
    Wacker A; Scheel-Walter HG; Neunhoeffer F
    Z Geburtshilfe Neonatol; 2009 Apr; 213(2):64-6. PubMed ID: 19319796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient myeloproliferative disorder and non-immune hydrops fetalis in a neonate with trisomy 21.
    Hon KL; Leung TY
    Hong Kong Med J; 2014 Feb; 20(1):78.e3-e4. PubMed ID: 24473698
    [No Abstract]   [Full Text] [Related]  

  • 10. Transient myeloproliferative disorder and eosinophilic pericardial effusion in a down syndrome neonate.
    Shenoy RD; Bhat KG; Kamath N; Kumble Y
    Pediatr Hematol Oncol; 2008 Mar; 25(2):123-9. PubMed ID: 18363179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-derived growth factor may be associated with fibrosis in a Down syndrome patient with transient myeloproliferative disorder.
    Ogawa J; Kanegane H; Tsuneyama K; Kanezaki R; Futatani T; Nomura K; Ishizawa S; Sasahara M; Ito E; Miyawaki T
    Eur J Haematol; 2008 Jul; 81(1):58-64. PubMed ID: 18331602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse hepatic fibrosis with transient myeloproliferative disorders in Down syndrome.
    Hongeng S; Pakakasama S; Hathirat P; Phuapradid P; Worapongpaiboon S
    J Pediatr Hematol Oncol; 2000; 22(6):543-4. PubMed ID: 11132225
    [No Abstract]   [Full Text] [Related]  

  • 13. Osteopontin expression in the liver with severe perisinusoidal fibrosis: autopsy case of Down syndrome with transient myeloproliferative disorder.
    Tokairin T; Nishikawa Y; Watanabe H; Doi Y; Omori Y; Yoshioka T; Yamamoto Y; Yoshida M; Nishimura T; Li Q; Arai H; Ishida A; Takada G; Enomoto K
    Pathol Int; 2008 Jan; 58(1):64-8. PubMed ID: 18067644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unusual hepatic fibrosis in three cases of Down syndrome].
    Inoue T; Kobayashi Y; Kusuda S
    Rinsho Byori; 1996 Jun; 44(6):590-4. PubMed ID: 8752740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diffuse liver fibrosis associated with transient myeloproliferative disorder in Down's syndrome].
    Villamor Zambrano E; Alonso Ortiz T; Arizcun Pineda J; Moro Serrano M
    An Esp Pediatr; 1997 Jul; 47(1):69-70. PubMed ID: 9382333
    [No Abstract]   [Full Text] [Related]  

  • 16. Down syndrome, transient myeloproliferative disorder, and infantile liver fibrosis.
    Schwab M; Niemeyer C; Schwarzer U
    Med Pediatr Oncol; 1998 Sep; 31(3):159-65. PubMed ID: 9722898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient abnormal myelopoiesis accompanied by hepatic fibrosis in two infants with Down syndrome.
    Yagihashi N; Watanabe K; Yagihashi S
    J Clin Pathol; 1995 Oct; 48(10):973-5. PubMed ID: 8537505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient myeloproliferative disorder in neonates with and without Down syndrome: a tale of 2 syndromes.
    Apollonsky N; Shende A; Ouansafi I; Brody J; Atlas M; Aygun B
    J Pediatr Hematol Oncol; 2008 Nov; 30(11):860-4. PubMed ID: 18989165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic assessment of hydrops foetalis secondary to transient myeloproliferative disorder associated with foetal Down syndrome: A case report and literature review.
    Traisrisilp K; Charoenkwan P; Tongprasert F; Srisupundit K; Tongsong T
    J Obstet Gynaecol; 2016 Oct; 36(7):861-864. PubMed ID: 27612526
    [No Abstract]   [Full Text] [Related]  

  • 20. Prenatal diagnosis of a transient myeloproliferative disorder in trisomy 21.
    Baschat AA; Wagner T; Malisius R; Gembruch U
    Prenat Diagn; 1998 Jul; 18(7):731-6. PubMed ID: 9706656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.